Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-23Double-Blind, Placebo-Controlled, Randomized Trial of Adjunctive Lisdexamfetamine Dimesylate in Residual Symptoms of Major Depressive Disorder Partially Responsive to Selective Serotonin or Norepinephrine Reuptake Inhibitor Monotherapy
-
CLINICAL_TRIALS study record update · 2017-05-19Comparison of Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Magnetic Resonance Spectroscopy (MRS) as Bioenergetic Imaging Modalities in Healthy Human Brain and Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2017-05-10Pioglitazone Treatment for Insulin Resistant Patients With Mood Disorders
-
CLINICAL_TRIALS study record update · 2017-05-09A Pilot Study of Double-blind Comparison of Vilazodone to Paroxetine in Geriatric Depression
-
CLINICAL_TRIALS study record update · 2017-05-08A Preliminary Clinical Study on the Rapid Antidepressant Effects of Adenosine Triphosphate (ATP) and Phosphocreatine Combinated With Fluoxetine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-05-05Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
-
CLINICAL_TRIALS study record update · 2017-05-05A Double-Blind, Multicenter, Placebo-Controlled Study of MK0869 in the Treatment of Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2017-05-05A Double-Blind, Multicenter, Placebo Controlled, Acute and Extension Study of 2 Doses of MK0869 in the Treatment of Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2017-05-05A Double-Blind, Multicenter, Placebo and Active-Controlled, Acute Extension Study of 2 Doses of MK-0869 in the Treatment of Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2017-05-05A Double-Blind, Placebo-Controlled, Multicenter Study of the Long-Term Efficacy of MK0869 in the Maintenance of Antidepressant Effect in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2017-05-05A Double-Blind, Placebo-Controlled, Multicenter Study of the Long-Term Efficacy of MK0869 in the Maintenance of Antidepressant Effect in Geriatric Outpatients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2017-05-03Pharmacogenetic Testing in an Outpatient Population of Patients With Major Depressive Disorder or Depressive Disorder Not Otherwise Specified With Avera Medical Group Clinics
-
CLINICAL_TRIALS study record update · 2017-05-02A Comparison of Cognitive and Dynamic Therapy for MDD in Community Settings
-
CLINICAL_TRIALS study record update · 2017-04-27Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
-
CLINICAL_TRIALS study record update · 2017-04-26Stimulant Enhancement of Well-Being Therapy for Depression
-
CLINICAL_TRIALS study record update · 2017-04-26A Worldwide, Multicenter, Double-Blind, Parallel, Active-Controlled, Long-Term Safety Study of MK0869 in Outpatients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2017-04-21PET Imaging of mGluR5 With Drug Challenge
-
CLINICAL_TRIALS study record update · 2017-04-20The Effect and Reliability of Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
-
CLINICAL_TRIALS study record update · 2017-04-20Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial
-
CLINICAL_TRIALS study record update · 2017-04-20N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation
-
CLINICAL_TRIALS study record update · 2017-04-20Measuring Adherence to Standard-of-Care Medication for Depression and ADHD in a College Student Population
-
CLINICAL_TRIALS study record update · 2017-04-20Randomized, Double-blind Ketamine Augmentation in Chronically Suicidal, Treatment-resistant Major Depression
-
CLINICAL_TRIALS study record update · 2017-04-18A Double-Blind, Multicenter, Placebo- and Active-Controlled Acute and Extension Study of MK0869 in the Treatment of Patients With Major Depressive Disorder With Melancholic Features
-
CLINICAL_TRIALS study record update · 2017-04-18A Double-Blind, Multicenter, Placebo-and Active-Controlled Acute and Extension Study of 2 Doses of MK-0869 in the Treatment of Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2017-04-14ClinicalTrials.gov study NCT01260649